Dryden Capital’s Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AVAN.WS Stock Holding History

Dryden Capital’s Portfolio AVAN.WS Stock Details AVAN.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,000	Closed	–	–	62
2022 Q3	$0	Hold	15,000	–	–	﹤0.01%	61
2022 Q2	$1K	Hold	15,000	–	–	﹤0.01%	57
2022 Q1	$4K	Buy	+15,000	New	+$5.41K	﹤0.01%	53

Dryden Capital's AVAN.WS Position: Q4 2022 in Review

Dryden Capital sold out of Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AVAN.WS) in Q4 2022, closing a stake of 15,000 shares.

Dryden Capital first reported a position in AVAN.WS in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold AVAN.WS as of Q4 2022.

Dryden Capital reported no remaining Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
Dryden Capital sold 15,000 Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022.
Dryden Capital first reported a position in Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
Dryden Capital's Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $4K in Q1 2022.
0 funds tracked by Wall St. Rank held Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Dryden Capital's 13F filing for Q4 2022, filed 14 Feb 2023.